This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Development Center for Biotechnology. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: King-Song Jeng: Innovator in Biotechnology
Introduction
King-Song Jeng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and enzymes. With a total of 2 patents to his name, Jeng continues to push the boundaries of scientific innovation.
Latest Patents
Jeng's latest patents include groundbreaking work on the swine vesicular disease virus (SVDV) and recombinant xylanase. The first patent focuses on a gene of SVDV and its mutant strains, detailing a preparation process and the use of these strains in a vaccine for the prophylaxis of swine vesicular disease. This invention also provides a method for differentiating mutant strains of SVDV from wild type strains using polymerase chain reaction. The second patent presents a genetically recombinant xylanase that boasts high yield and good activity, along with a process for its production. This invention includes the coding sequence of the recombinant enzyme, vectors bearing this sequence, and transformants containing the vectors.
Career Highlights
King-Song Jeng is affiliated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in his field. His work has not only contributed to scientific knowledge but also has practical applications in agriculture and medicine.
Collaborations
Jeng has collaborated with notable colleagues, including Edward L. Chang and Ying-Chuan Yang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
King-Song Jeng is a distinguished inventor whose work in biotechnology has led to significant advancements in vaccine development and enzyme production. His contributions continue to impact the scientific community and the industries that rely on biotechnological innovations.